Table 1.
(Vectibix [tiab] OR panitumumab [tiab] OR ABX-EGF [tiab] OR Panitumumab [nm] OR Erbitux [tiab] OR cetuximab [tiab] OR IMC-C225 [tiab] OR Cetuximab [nm] OR nimotuzumab [tiab] OR Theracim [tiab] OR Theraloc [tiab] OR “BIOMAb EGFR” [tiab] OR matuzumab [tiab] OR “EMD 72000” [tiab] OR zalutumumab [tiab] OR EGFR [tiab] OR HuMax-EGFR [tiab]) |
AND |
(Colorectal [tiab] OR colon [tiab] OR rectum [tiab] OR rectal [tiab] OR colonic [tiab]) |
AND |
(skin [tiab] OR rash [tiab] OR integument [tiab] OR dermatitis [tiab] OR stomatitis [tiab] OR pruritus [tiab] OR papulopustular [tiab] OR acne [tiab] OR “dry skin” [tiab] OR eczema [tiab] OR nail [tiab] OR erythrodysesthesia [tiab] OR erythrodysaesthesia [tiab] OR erythema [tiab] OR paronychia [tiab] OR eye [tiab] OR retina [tiab] OR Acanthosis [tiab] OR acne pustular [tiab] OR angiokeratoma [tiab] OR blister [tiab] OR capillaritis [tiab] OR cataract [tiab] OR cellulitis [tiab] OR chorioretinitis [tiab] OR conjunctivitis [tiab] OR corneal [tiab] OR acneiform [tiab] OR herpetiformis [tiab] OR psoriasiform [tiab] OR eosinophilia [tiab] OR dry eye [tiab] OR dry skin [tiab] OR endophthalmitis [tiab] OR exfoliative [tiab] OR eye pruritus [tiab] OR eyelash thickening [tiab] OR eyelids pruritus [tiab] OR hyperkeratosis [tiab] OR keratitis [tiab] OR nail bed inflammation [tiab] OR nail psoriasis [tiab] OR optic neuropathy [tiab] OR palmar erythema [tiab] OR palmar-plantar erythrodysaesthesia syndrome [tiab] OR palmar-plantar erythrodysesthesia syndrome [tiab] OR perivascular dermatitis [tiab] OR petechiae [tiab] OR plantar erythema [tiab] OR psoriasis [tiab] OR pustular psoriasis [tiab] OR rash papular [tiab] OR papulosquamous [tiab] OR pruritic [tiab] OR rash pustular [tiab] OR xeroderma [tiab] OR retinitis [tiab] OR exfoliation [tiab] OR photosensitivity [tiab] OR onycholysis [tiab] OR maceration [tiab] OR erythematous [tiab] OR hair [tiab] OR ulceration [tiab] OR alopecia [tiab] OR folliculitis [tiab] OR maculo-papular [tiab] OR “vision blurred” [tiab] OR “blurred vision” [tiab] OR cheilitis [tiab] OR excoriation [tiab] OR hypertrichosis [tiab] OR hyperpigmentation [tiab] OR urticaria [tiab] OR conjunctival [tiab] OR “eye swelling” [tiab] OR hirsutism [tiab] OR “ingrowing nail” [tiab] OR “lip dry” [tiab] OR onychoclasis [tiab] OR papule [tiab] OR pigmentation [tiab] OR scab [tiab] OR xerosis [tiab] OR abscess [tiab] OR fissure [tiab] OR eyelid [tiab] OR eyes [tiab] OR nails [tiab] OR eyelashes [tiab] OR hordeolum [tiab] OR dermal [tiab] OR intertrigo [tiab] OR macular [tiab] OR ocular [tiab] OR onychomadesis [tiab] OR onychomycosis [tiab] OR otitis [tiab] OR periorbital [tiab] OR seborrhoea [tiab] OR seborrhoeic [tiab] OR purpura [tiab] OR sunburn [tiab] OR retinopathy [tiab] OR dermatologic [tiab] OR dermatology [tiab] OR dermatologist [tiab] OR soap [tiab] OR cream [tiab] OR “topical steroid” [tiab] OR hydrocortisone [tiab] OR moisturizer [tiab] OR sunscreen [tiab] OR Lubriderm [tiab] OR PABA [tiab] OR SPF [tiab] OR doxycycline [tiab] OR “hair changes” [tiab] OR) |
AND |
(“2009/01/01”[PDAT]: ”2016/8/18“[PDAT]”) |
Abbreviations: nm = supplementary concept; PDAT = publication date; Tiab = title or abstract.